Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Striatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies.

Hienert M, Gryglewski G, Stamenkovic M, Kasper S, Lanzenberger R.

Transl Psychiatry. 2018 Aug 2;8(1):143. doi: 10.1038/s41398-018-0202-y.

2.

Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI.

Rischka L, Gryglewski G, Pfaff S, Vanicek T, Hienert M, Klöbl M, Hartenbach M, Haug A, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Hahn A.

Neuroimage. 2018 Nov 1;181:323-330. doi: 10.1016/j.neuroimage.2018.06.079. Epub 2018 Jun 30.

PMID:
29966719
3.

SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18F]FE@SNAP and [11C]SNAP-7941.

Philippe C, Zeilinger M, Dumanic M, Pichler F, Fetty L, Vraka C, Balber T, Wadsak W, Pallitsch K, Spreitzer H, Lanzenberger R, Hacker M, Mitterhauser M.

Mol Imaging Biol. 2018 Jun 13. doi: 10.1007/s11307-018-1212-0. [Epub ahead of print]

PMID:
29948643
4.

Towards quantitative [18F]FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates.

Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass EM, Füchsel FG, Hacker M, Pilz M, Pataraia E, Traub-Weidinger T, Beyer T.

J Cereb Blood Flow Metab. 2018 May 23:271678X18776820. doi: 10.1177/0271678X18776820. [Epub ahead of print]

PMID:
29790820
5.

Cortical Thickness Estimations of FreeSurfer and the CAT12 Toolbox in Patients with Alzheimer's Disease and Healthy Controls.

Seiger R, Ganger S, Kranz GS, Hahn A, Lanzenberger R.

J Neuroimaging. 2018 May 15. doi: 10.1111/jon.12521. [Epub ahead of print]

PMID:
29766613
6.

Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging.

Gryglewski G, Seiger R, James GM, Godbersen GM, Komorowski A, Unterholzner J, Michenthaler P, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R.

Neuroimage. 2018 Aug 1;176:259-267. doi: 10.1016/j.neuroimage.2018.04.068. Epub 2018 May 1.

PMID:
29723639
7.

DiGeorge syndrome : Relevance of psychiatric symptoms in undiagnosed adult patients.

Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S.

Wien Klin Wochenschr. 2018 Apr;130(7-8):283-287. doi: 10.1007/s00508-018-1335-y. Epub 2018 Apr 18.

8.

Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Nørgaard M, Ganz M, Svarer C, Feng L, Ichise M, Lanzenberger R, Lubberink M, Parsey RV, Politis M, Rabiner EA, Slifstein M, Sossi V, Suhara T, Talbot PS, Turkheimer F, Strother SC, Knudsen GM.

J Cereb Blood Flow Metab. 2018 Apr 13:271678X18770107. doi: 10.1177/0271678X18770107. [Epub ahead of print]

PMID:
29651896
9.

[18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer.

Berroterán-Infante N, Balber T, Fürlinger P, Bergmann M, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W.

ACS Med Chem Lett. 2018 Feb 21;9(3):177-181. doi: 10.1021/acsmedchemlett.7b00367. eCollection 2018 Mar 8.

PMID:
29541356
10.

Correction to: The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI.

Kraus C, Klöbl M, Tik M, Auer B, Vanicek T, Geissberger N, Pfabigan DM, Hahn A, Woletz M, Paul K, Komorowski A, Kasper S, Windischberger C, Lamm C, Lanzenberger R.

Mol Psychiatry. 2018 Mar 8. doi: 10.1038/s41380-018-0032-6. [Epub ahead of print]

PMID:
29520037
11.

The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI.

Kraus C, Klöbl M, Tik M, Auer B, Vanicek T, Geissberger N, Pfabigan DM, Hahn A, Woletz M, Paul K, Komorowski A, Kasper S, Windischberger C, Lamm C, Lanzenberger R.

Mol Psychiatry. 2018 Feb 8. doi: 10.1038/s41380-017-0009-x. [Epub ahead of print] Erratum in: Mol Psychiatry. 2018 Mar 8;:.

PMID:
29422521
12.

Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers.

Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S, Lanzenberger R.

Neuroimage. 2018 May 1;171:1-5. doi: 10.1016/j.neuroimage.2017.12.092. Epub 2017 Dec 29.

PMID:
29292133
13.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m11385. doi: 10.4088/JCP.16m11385.

PMID:
29228516
14.

Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity.

Hahn A, Gryglewski G, Nics L, Rischka L, Ganger S, Sigurdardottir H, Vraka C, Silberbauer L, Vanicek T, Kautzky A, Wadsak W, Mitterhauser M, Hartenbach M, Hacker M, Kasper S, Lanzenberger R.

Brain Struct Funct. 2018 Apr;223(3):1369-1378. doi: 10.1007/s00429-017-1558-0. Epub 2017 Nov 13.

15.

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.

Spies M, James GM, Berroterán-Infante N, Ibeschitz H, Kranz GS, Unterholzner J, Godbersen M, Gryglewski G, Hienert M, Jungwirth J, Pichler V, Reiter B, Silberbauer L, Winkler D, Mitterhauser M, Stimpfl T, Hacker M, Kasper S, Lanzenberger R.

Int J Neuropsychopharmacol. 2018 Feb 1;21(2):145-153. doi: 10.1093/ijnp/pyx085.

16.

Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals.

Kranz GS, Hahn A, Kaufmann U, Tik M, Ganger S, Seiger R, Hummer A, Windischberger C, Kasper S, Lanzenberger R.

Brain Struct Funct. 2018 Jan;223(1):321-328. doi: 10.1007/s00429-017-1494-z. Epub 2017 Aug 17.

17.

In vivo evaluation of radiotracers targeting the melanin-concentrating hormone receptor 1: [11C]SNAP-7941 and [18F]FE@SNAP reveal specific uptake in the ventricular system.

Zeilinger M, Dumanic M, Pichler F, Budinsky L, Wadsak W, Pallitsch K, Spreitzer H, Lanzenberger R, Hacker M, Mitterhauser M, Philippe C.

Sci Rep. 2017 Aug 14;7(1):8054. doi: 10.1038/s41598-017-08684-6.

18.

Ketamine for the Treatment of Depression.

Kraus C, Lanzenberger R, Kasper S.

JAMA Psychiatry. 2017 Sep 1;74(9):970. doi: 10.1001/jamapsychiatry.2017.1770. No abstract available.

PMID:
28700802
19.

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.

Kautzky A, James GM, Philippe C, Baldinger-Melich P, Kraus C, Kranz GS, Vanicek T, Gryglewski G, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

Transl Psychiatry. 2017 Jun 13;7(6):e1150. doi: 10.1038/tp.2017.108.

20.

Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression.

Kraus C, Castrén E, Kasper S, Lanzenberger R.

Neurosci Biobehav Rev. 2017 Jun;77:317-326. doi: 10.1016/j.neubiorev.2017.03.007. Epub 2017 Mar 22. Review.

PMID:
28342763
21.

PET/MRI for Oncologic Brain Imaging: A Comparison of Standard MR-Based Attenuation Corrections with a Model-Based Approach for the Siemens mMR PET/MR System.

Rausch I, Rischka L, Ladefoged CN, Furtner J, Fenchel M, Hahn A, Lanzenberger R, Mayerhoefer ME, Traub-Weidinger T, Beyer T.

J Nucl Med. 2017 Sep;58(9):1519-1525. doi: 10.2967/jnumed.116.186148. Epub 2017 Mar 2.

22.

Task-dependent modulation of amygdala connectivity in social anxiety disorder.

Minkova L, Sladky R, Kranz GS, Woletz M, Geissberger N, Kraus C, Lanzenberger R, Windischberger C.

Psychiatry Res Neuroimaging. 2017 Apr 30;262:39-46. doi: 10.1016/j.pscychresns.2016.12.016. Epub 2017 Feb 9.

23.

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.

James GM, Baldinger-Melich P, Philippe C, Kranz GS, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R.

Front Hum Neurosci. 2017 Feb 6;11:48. doi: 10.3389/fnhum.2017.00048. eCollection 2017.

24.

Effects of sex hormone treatment on white matter microstructure in individuals with gender dysphoria.

Kranz GS, Seiger R, Kaufmann U, Hummer A, Hahn A, Ganger S, Tik M, Windischberger C, Kasper S, Lanzenberger R.

Neuroimage. 2017 Apr 15;150:60-67. doi: 10.1016/j.neuroimage.2017.02.027. Epub 2017 Feb 13.

PMID:
28196668
25.

Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.

Gryglewski G, Rischka L, Philippe C, Hahn A, James GM, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R.

Neuroimage. 2017 Apr 1;149:23-32. doi: 10.1016/j.neuroimage.2017.01.050. Epub 2017 Jan 22.

PMID:
28119137
26.

Default mode network deactivation during emotion processing predicts early antidepressant response.

Spies M, Kraus C, Geissberger N, Auer B, Klöbl M, Tik M, Stürkat IL, Hahn A, Woletz M, Pfabigan DM, Kasper S, Lamm C, Windischberger C, Lanzenberger R.

Transl Psychiatry. 2017 Jan 24;7(1):e1008. doi: 10.1038/tp.2016.265.

27.

Unsmoothed functional MRI of the human amygdala and bed nucleus of the stria terminalis during processing of emotional faces.

Sladky R, Geissberger N, Pfabigan DM, Kraus C, Tik M, Woletz M, Paul K, Vanicek T, Auer B, Kranz GS, Lamm C, Lanzenberger R, Windischberger C.

Neuroimage. 2018 Mar;168:383-391. doi: 10.1016/j.neuroimage.2016.12.024. Epub 2017 Jan 17.

PMID:
28108394
28.

Administration of ketamine for unipolar and bipolar depression.

Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski JK, Kasper S.

Int J Psychiatry Clin Pract. 2017 Mar;21(1):2-12. doi: 10.1080/13651501.2016.1254802. Epub 2017 Jan 18. Review.

PMID:
28097909
29.

A New Prediction Model for Evaluating Treatment-Resistant Depression.

Kautzky A, Baldinger-Melich P, Kranz GS, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2017 Feb;78(2):215-222. doi: 10.4088/JCP.15m10381.

PMID:
28068461
30.

Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control.

Höflich A, Ganger S, Tik M, Hahn A, Kranz GS, Vanicek T, Spies M, Kraus C, Windischberger C, Kasper S, Winkler D, Lanzenberger R.

Neuroimage. 2017 Feb 15;147:198-203. doi: 10.1016/j.neuroimage.2016.12.032. Epub 2016 Dec 13.

PMID:
27986606
31.

Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain.

Komorowski A, James GM, Philippe C, Gryglewski G, Bauer A, Hienert M, Spies M, Kautzky A, Vanicek T, Hahn A, Traub-Weidinger T, Winkler D, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R.

Cereb Cortex. 2017 Jan 1;27(1):117-130. doi: 10.1093/cercor/bhw355.

32.

Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.

Vanicek T, Kutzelnigg A, Philippe C, Sigurdardottir HL, James GM, Hahn A, Kranz GS, Höflich A, Kautzky A, Traub-Weidinger T, Hacker M, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2017 Feb;38(2):792-802. doi: 10.1002/hbm.23418. Epub 2016 Oct 22.

PMID:
27770470
33.

Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.

Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG, Smith R, Hansson O.

J Nucl Med. 2017 Apr;58(4):623-631. doi: 10.2967/jnumed.116.174508. Epub 2016 Oct 20.

34.

Has the existence of seasonal affective disorder been disproven?

Winkler D, Pjrek E, Spies M, Willeit M, Dorffner G, Lanzenberger R, Kasper S.

J Affect Disord. 2017 Jan 15;208:54-55. doi: 10.1016/j.jad.2016.08.041. Epub 2016 Oct 3. No abstract available.

PMID:
27744127
35.

Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration.

Seiger R, Hahn A, Hummer A, Kranz GS, Ganger S, Woletz M, Kraus C, Sladky R, Kautzky A, Kasper S, Windischberger C, Lanzenberger R.

Psychoneuroendocrinology. 2016 Dec;74:371-379. doi: 10.1016/j.psyneuen.2016.09.028. Epub 2016 Oct 5.

PMID:
27744092
36.

Ketamine-dependent neuronal activation in healthy volunteers.

Höflich A, Hahn A, Küblböck M, Kranz GS, Vanicek T, Ganger S, Spies M, Windischberger C, Kasper S, Winkler D, Lanzenberger R.

Brain Struct Funct. 2017 Apr;222(3):1533-1542. doi: 10.1007/s00429-016-1291-0. Epub 2016 Aug 30.

PMID:
27578365
37.

Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.

Bailey DL, Pichler BJ, Gückel B, Barthel H, Beer AJ, Botnar R, Gillies R, Goh V, Gotthardt M, Hicks RJ, Lanzenberger R, la Fougere C, Lentschig M, Nekolla SG, Niederdraenk T, Nikolaou K, Nuyts J, Olego D, Riklund KÅ, Signore A, Schäfers M, Sossi V, Suminski M, Veit-Haibach P, Umutlu L, Wissmeyer M, Beyer T.

Mol Imaging Biol. 2016 Oct;18(5):637-50. doi: 10.1007/s11307-016-0993-2.

38.

Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18F-FDG.

Hahn A, Gryglewski G, Nics L, Hienert M, Rischka L, Vraka C, Sigurdardottir H, Vanicek T, James GM, Seiger R, Kautzky A, Silberbauer L, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R.

J Nucl Med. 2016 Dec;57(12):1933-1940. Epub 2016 Jul 7. Erratum in: J Nucl Med. 2017 Feb;58(2):356. J Nucl Med. 2018 Mar;59(3):468.

39.

Insights into Intrinsic Brain Networks based on Graph Theory and PET in right- compared to left-sided Temporal Lobe Epilepsy.

Vanicek T, Hahn A, Traub-Weidinger T, Hilger E, Spies M, Wadsak W, Lanzenberger R, Pataraia E, Asenbaum-Nan S.

Sci Rep. 2016 Jun 28;6:28513. doi: 10.1038/srep28513.

40.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.

Schmitt A, Rujescu D, Gawlik M, Hasan A, Hashimoto K, Iceta S, Jarema M, Kambeitz J, Kasper S, Keeser D, Kornhuber J, Koutsouleris N, Lanzenberger R, Malchow B, Saoud M, Spies M, Stöber G, Thibaut F, Riederer P, Falkai P; WFSBP Task Force on Biological Markers.

World J Biol Psychiatry. 2016 Sep;17(6):406-28. doi: 10.1080/15622975.2016.1183043. Epub 2016 Jun 17.

PMID:
27311987
41.

[(18)F]FMeNER-D2: A systematic in vitro analysis of radio-metabolism.

Rami-Mark C, Eberherr N, Berroterán-Infante N, Vanicek T, Nics L, Lanzenberger R, Hacker M, Wadsak W, Mitterhauser M.

Nucl Med Biol. 2016 Aug;43(8):490-5. doi: 10.1016/j.nucmedbio.2016.05.004. Epub 2016 May 13.

PMID:
27236284
42.

Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging.

Spies M, Hahn A, Kranz GS, Sladky R, Kaufmann U, Hummer A, Ganger S, Kraus C, Winkler D, Seiger R, Comasco E, Windischberger C, Kasper S, Lanzenberger R.

Neuroimage. 2016 Sep;138:257-265. doi: 10.1016/j.neuroimage.2016.05.060. Epub 2016 May 26.

PMID:
27236082
43.

Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression.

Cumming P, Gryglewski G, Kranz GS, Lanzenberger R.

J Affect Disord. 2016 Jul 15;199:21-2. doi: 10.1016/j.jad.2016.03.058. Epub 2016 Mar 29. No abstract available.

PMID:
27057649
44.

The 26th Danube Symposium of Psychiatry: Psychiatry - ready for the future?

Palm U, Musil R, Ienciu M, Jakovljevic M, Kapfhammer HP, Kasper S, Keck ME, Langguth B, Lanzenberger R, Meisenzahl E, Möller HJ, Müller N, Nedopil N, Sartorius N, Schöny W, Falkai P.

Psychiatr Danub. 2016 Mar;28(1):95-6. No abstract available.

45.

Testosterone affects language areas of the adult human brain.

Hahn A, Kranz GS, Sladky R, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Vanicek T, Winkler D, Kasper S, Windischberger C, Swaab DF, Lanzenberger R.

Hum Brain Mapp. 2016 May;37(5):1738-48. doi: 10.1002/hbm.23133. Epub 2016 Feb 15.

46.

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.

Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2016 Mar;37(3):884-95. doi: 10.1002/hbm.23071. Epub 2015 Dec 17.

47.

Imaging brain circuits in anxiety disorders.

Kasper S, Gryglewski G, Lanzenberger R.

Lancet Psychiatry. 2014 Sep;1(4):251-2. doi: 10.1016/S2215-0366(14)70348-7. Epub 2014 Aug 27. No abstract available. Erratum in: Lancet Psychiatry. 2015 Mar;2(3):204.

48.

The serotonin transporter in psychiatric disorders: insights from PET imaging.

Spies M, Knudsen GM, Lanzenberger R, Kasper S.

Lancet Psychiatry. 2015 Aug;2(8):743-755. doi: 10.1016/S2215-0366(15)00232-1. Review.

PMID:
26249305
49.

Comparison of continuously acquired resting state and extracted analogues from active tasks.

Ganger S, Hahn A, Küblböck M, Kranz GS, Spies M, Vanicek T, Seiger R, Sladky R, Windischberger C, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2015 Oct;36(10):4053-63. doi: 10.1002/hbm.22897. Epub 2015 Jul 15.

50.

Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI.

Rami-Mark C, Berroterán-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W.

EJNMMI Res. 2015 Dec;5(1):113. doi: 10.1186/s13550-015-0113-3. Epub 2015 Jun 10.

Supplemental Content

Loading ...
Support Center